A critical breakthrough in cancer research is occurring with the use of VHH fragments to reactivate mutated p53. This vital malignant suppressor protein is frequently inactivated in several forms of malignancies, https://directmysocial.com/story6743439/nanobodies-reactivate-the-p53-protein-new-new-pathway-for-malignant-management